SCHEMBL25600604

SCHEMBL25600604

COP(O)(=S)OCCOCCOCCOCCNC(=O)CCCCC1SCC2NC(=O)NC21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 2/20 0.67
▸ PRSS2 P07478 2/20 0.67
▸ PRSS3 P35030 2/20 0.67
▸ TPSAB1 Q15661 2/20 0.67
▸ F2 P00734 1/20 0.67
▸ PKM P14618 3/20 0.59
▸ FOLH1 Q04609 3/20 0.57
▸ TDP1 Q9NUW8 5/20 0.56
▸ PLCD1 P51178 1/20 0.55
▸ HSP90AB1 P08238 1/20 0.51
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ CSNK2A2 P19784 1/20 0.49
▸ CSNK2B P67870 1/20 0.49
▸ CSNK2A1 P68400 1/20 0.49
▸ CAMK2B Q13554 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ ABL1 P00519 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26550315 0.90 PRSS1 (0.71) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL23868666 0.90 PRSS1 (0.71) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL26550330 0.88 PRSS1 (0.72) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL23868667 0.88 PRSS1 (0.72) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL19017236 0.88 F2 (0.73) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL19751698 0.88 F2 (0.73) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL4968230 0.88 F2 (0.73) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL15216220 0.88 F2 (0.73) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL13827288 0.87 F2 (0.73) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL15308144 0.87 F2 (0.73) PRSS1PRSS2PRSS3TPSAB1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158156-A1 BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF FLAGSHIP PIONEERING, INC. (US) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158156-A1 BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF EFTUD2, SNRPE, DDX21 PRSS1 2054/4885PRSS2 1565/4885PRSS3 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback